Skip to content
A344Assembly2021-2022 SessionSame asS1776

Ban Tianeptine Sodium Sales

Official title

“Adds tianeptine sodium to the list of Schedule II of controlled substances”

Sponsor Edward BraunsteinAD-26Affects Health
Status
In Assembly Committee
Health
Impact
4/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill classifies tianeptine sodium as a Schedule II controlled substance in New York.

Why it matters

  1. Classifying tianeptine sodium as a Schedule II controlled substance means it is recognized as having a high potential for abuse, with use potentially leading to severe psychological or physical dependence. This change would impose stricter regulations on its prescription, distribution, and possession in New York.

  2. The amendment reflects growing concerns about tianeptine’s misuse and associated health risks, including reports of addiction, withdrawal symptoms, and overdose cases elsewhere in the U.S. By controlling the substance, New York aims to address possible public health and safety threats before they escalate.

  3. Healthcare providers, pharmacies, and patients would face new legal requirements and oversight regarding tianeptine sodium. This could impact access for any legitimate medical uses, and may also influence research, as stricter protocols would be needed for handling and studying the substance.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Tianeptine sodium sellers

    The bill would place the substance they sell under Schedule II controls.

  • People using tianeptine sodium

    The bill would classify the substance they use as a Schedule II controlled substance.

  • Controlled-substance regulators

    The bill would add tianeptine sodium to New York’s Schedule II list.

Headline styles

Ban Tianeptine Sodium Sales

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Edward Braunstein

Assembly Member · Assembly District 26

Chair, Corporations, Authorities and Commissions

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S1776Senate

Restrict Tianeptine Sodium Use

In Senate Committee · Health · Sponsor James Skoufis

Impact 4 · Low0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

344

2021-2022 Regular Sessions

IN ASSEMBLY (Prefiled)

January 6, 2021

Introduced by M. of A. BRAUNSTEIN -- read once and referred to the Committee on Health

AN ACT to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision (e) of schedule II of section 3306 of the public health law is amended by adding a new paragraph 5 to read as follows:

(5) Tianeptine sodium.

§ 2. This act shall take effect on the ninetieth day after it shall have become a law.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD03419-01-1

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.